Sept 25 (Reuters) -
* INFORMATION UPDATE - HEALTH CANADA REQUESTS THAT COMPANIES STOP DISTRIBUTING RANITIDINE DRUGS IN CANADA WHILE IT ASSESSES NDMA; ADDITIONAL PRODUCTS BEING RECALLED
* HEALTH CANADA - ADDITIONAL RANITIDINE DRUGS ARE BEING RECALLED BY 4 COS: APOTEX, PRO DOC LIMITÉE, SANIS HEALTH & SIVEM PHARMACEUTICALS ULC